Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 6, 2006, Pages

  Gerber, Lamar K ^a   Aronow, Bruce J ^a   Matlib, Mohammed A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetes; Fatty acid oxidation; Gene array; Lipotoxic cardiomyopathy

Indexed keywords

ACYL COENZYME A; HYDROLYASE; LIPOSOME; LONG CHAIN FATTY ACID; PALMITIC ACID; PALMITOYLCARNITINE; STREPTOZOCIN; THIOL ESTER HYDROLASE; UNCOUPLING PROTEIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE OVEREXPRESSION; HEART MITOCHONDRION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ANIMALS; ATRACTYLOSIDE; BIOLOGICAL TRANSPORT; CELL RESPIRATION; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; ION CHANNELS; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; OLIGOMYCINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PALMITIC ACID; PALMITOYL-COA HYDROLASE; RATS; RATS, WISTAR; UNCOUPLING AGENTS;

EID: 33845308581     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00246.2006     Document Type: Article

References (41)

1. Andreyev AY, Bondareva TO, Dedukhova VI, Mokhova EN, Skulachev VP, and Volkov NI. Carboxyatractylate inhibits the uncoupling effects of free fatty acids. FEBS Lett 226: 265-269, 1988.
2. Alexson SHE and Nedergaard J. A novel type of short- and medium chain acyl-CoA hydrolases in brown adipose tissue mitochondria. J Biol Chem 263: 13564-13571, 1988.
3. Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, and Severson DL. Treatment of type 2 diabetic db/db mice with novel PPARγ agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 286: E449-E455, 2004.
4. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz J, and Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. Clin Investig 107: 813-822, 2001.
5. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283: H1398-H1408, 2002.
6. Draghici S, Khatri P, Martins RP, Ostermeier GC, and Krawetz SA. Global functional profiling of gene expression. Genomics 81: 98-104, 2003.
7. Eaton S. Control of mitochondrial β-oxidation. Prog Lipid Res 41: 197-239, 2002.
8. Finck BN and Kelly DP. Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J Mol Cell Cardiol 34: 1249-1257, 2002.
9. Fink BN, Han X, Courtis M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, and Kelly DP. A critical role of PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100: 1226-1231, 2003.
10. Flarsheim CE, Grupp IL, and Matlib MA. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol Heart Circ Physiol 271: H192-H202, 1996.
11. Folch J, Lees M, and Sloane-Stanley GH. A simple method for the isolation and purification of the total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
12. Garlid KD, Jaburek M, Jezek P, and Varecha M. How do uncoupling proteins uncouple? Biochim Biophys Acta 1459: 383-389, 2000.
13. Golfman LS, Wilson CR, Sharma S, Burgmaier M, Young ME, Guthrie PH, Arsdall MV, Adrogue JV, Brown KK, and Taegtmeyer H. Activation of PPARγ enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab 289: E328-E336, 2005.
14. Hidaka S, Kakuma T, Yoshimatsu H, Sakino H, Fukuchi S, and Sakata T. Streptozotocin treatment upregulates uncoupling protein 3 expression in the rat heart. Diabetes 48: 430-439, 1999.
15. Himms-Hagen J and Harper ME. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: A hypothesis. Exp Biol Med (Maywood) 226: 78-84, 2001.
16. Hoit BD, Castro C, Bultron G, Knight S, and Matlib MA. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail 5: 324-333, 1999.
17. Hunt MC, Lindquist PJG, Peters JM, Gonzalez FJ, Diczfalusy U, and Alexson SHE. Involvement of peroxisome proliferator-activated receptor α in regulating long-chain acyl-CoA thioesterases. J Lipid Res 41: 814-823, 2000.
18. Jaburek M, Varecha M, Gimeno RE, Dembski M, Jazek P, Zhang M, Burn P, Tartaglia LA, and Garlid KD. Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem 274: 26003-26007, 1999.
19. Juburek M and Garlid KD. Reconstitution of recombinant uncoupling proteins. J Biol Chem 278: 25825-25831, 2003.
20. Kelly DP, Hale DE, Rutledge SL, Ogden ML, Whelan AJ, Zhang Z, and Strauss AW. Molecular basis of inherited medium-chain acyl-CoA dehydrogenase deficiency causing sudden child death. J Inherit Metab Dis 15: 171-180, 1992.
21. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, and Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53: 2366-2374, 2004.
22. Mutomba MC, Yuan H, Konyavko M, Adachi S, Yokoyama CB, Esser V, McGarry JD, Babior BM, and Gottlieb RA. Regulation of the activity of caspases by L-carnitine and palmitoyl-carnitine. FEBS Lett 478: 19-25, 2000.
23. Neely JR and Morgan HE. Myocardial utilization of carbohydrate and lipids. Annu Rev Physiol 36: 413-457, 1974.
24. 2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in diabetic heart. Diabetes 50: 2133-2138, 2001.
25. Requero MA, Goni FM, and Alonso A. The membrane-perturbing properties of palmitoyl-coenzyme A and palmitoyl-carnitine. A comparative study. Biochemistry 34: 10400-10405, 1995.
26. Saddik M and Lopaschuck GD. Triglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 72: 1110-1119, 1994.
27. Schrauwen P, Hinderling V, Hesselink KC, Schaart G, Kornips E, Saris WHM, Westerterp-Plantenga M, and Langhans W. Etomoxir-induced increase in UCP3 supports a role of uncoupling protein as a mitochondrial fatty acid anion exporter. FASEB J 16: 1688-1690, 2002.
28. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, and Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18: 1692-1700, 2004.
29. Shrago E, Woldegiorgis G, Ruoho AE, and DiRusso CC. Fatty acyl-CoA esters as regulators of cell metabolism. Prostaglandins Leukot Essent Fatty Acids 52: 163-166, 1995.
30. Sparagna GC, Hickson-Bick DL, Buja LM, and McMillin JB. A metabolic role of mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 279: H2124-H2132, 2000.
31. 31P NMR magnetization transfer study of the intact beating heart. J Mol Cell Cardiol 31: 2175-2189, 1999.
32. Stavinoha MA, RaySpellicy JW, Essop MF, Graveleau C, Abel ED, Hart-Sailors ML, Mersmann HJ, Bray MS, and Young ME. Evidence for mitochondrial thioesterase 1 as peroxisome proliferator-activated receptor-α-regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab 287: E888-E895, 2004.
33. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
34. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
35. 2+-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
36. Unger RH. The physiology of cellular liporegulation. Annu Rev Physiol 65: 333-347, 2003.
37. Unger RH and Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15: 312-321, 2001.
38. Wang HY, Baxter CF, and Schulz H. Regulation of fatty acid beta-oxidation in rat heart mitochondria. Arch Biochem Biophys 289: 274-280, 1991.
39. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, and Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in obese Zucker rat heart. Diabetes 51: 2587-2595, 2002.
40. Zhong Y, Ahmed S, Grupp IL, and Matlib MA. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 281: H1137-H1147, 2001.
41. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, and Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.